Annual Operating Profit:
-$577.37M+$22.08M(+3.68%)Summary
- As of today, BBIO annual operating income is -$577.37 million, with the most recent change of +$22.08 million (+3.68%) on December 31, 2024.
- During the last 3 years, BBIO annual operating profit has fallen by -$736.00 thousand (-0.13%).
- BBIO annual operating profit is now -1216.45% below its all-time high of -$43.86 million, reached on December 31, 2017.
Performance
BBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$133.47M-$29.67M(-28.58%)Summary
- As of today, BBIO quarterly operating income is -$133.47 million, with the most recent change of -$29.67 million (-28.58%) on June 30, 2025.
- Over the past year, BBIO quarterly operating profit has increased by +$39.17 million (+22.69%).
- BBIO quarterly operating profit is now -3665.94% below its all-time high of $3.74 million, reached on March 31, 2024.
Performance
BBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$645.74M+$39.17M(+5.72%)Summary
- As of today, BBIO TTM operating income is -$645.74 million, with the most recent change of +$39.17 million (+5.72%) on June 30, 2025.
- Over the past year, BBIO TTM operating profit has dropped by -$142.75 million (-28.38%).
- BBIO TTM operating profit is now -1443.42% below its all-time high of -$41.84 million, reached on March 31, 2018.
Performance
BBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BBIO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +3.7% | +22.7% | -28.4% |
| 3Y3 Years | -0.1% | -86.0% | -20.1% |
| 5Y5 Years | -116.9% | -7.2% | -51.7% |
BBIO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -23.3% | +3.7% | -3665.9% | +39.7% | -46.7% | +5.7% |
| 5Y | 5-Year | -116.9% | +3.7% | -3665.9% | +39.7% | -51.7% | +5.7% |
| All-Time | All-Time | -1216.5% | +3.7% | -3665.9% | +39.7% | -1443.4% | +5.7% |
BBIO Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$133.47M(-28.6%) | -$645.74M(+5.7%) |
| Mar 2025 | - | -$103.80M(+53.1%) | -$684.91M(-18.6%) |
| Dec 2024 | -$577.37M(+3.7%) | -$221.33M(-18.3%) | -$577.37M(-8.4%) |
| Sep 2024 | - | -$187.13M(-8.4%) | -$532.70M(-5.9%) |
| Jun 2024 | - | -$172.65M(-4712.6%) | -$502.99M(-6.4%) |
| Mar 2024 | - | $3.74M(+102.1%) | -$472.91M(+21.1%) |
| Dec 2023 | -$599.44M(-28.0%) | -$176.66M(-12.2%) | -$599.44M(-10.1%) |
| Sep 2023 | - | -$157.42M(-10.4%) | -$544.32M(-6.5%) |
| Jun 2023 | - | -$142.57M(-16.1%) | -$511.00M(-16.1%) |
| Mar 2023 | - | -$122.79M(-1.0%) | -$440.21M(+6.0%) |
| Dec 2022 | -$468.44M(+18.8%) | -$121.54M(+2.1%) | -$468.44M(+8.6%) |
| Sep 2022 | - | -$124.10M(-72.9%) | -$512.51M(+4.7%) |
| Jun 2022 | - | -$71.78M(+52.5%) | -$537.91M(+4.0%) |
| Mar 2022 | - | -$151.02M(+8.8%) | -$560.14M(+2.9%) |
| Dec 2021 | -$576.63M | -$165.61M(-10.8%) | -$576.63M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$149.50M(-59.0%) | -$538.51M(-5.8%) |
| Jun 2021 | - | -$94.02M(+43.9%) | -$508.95M(+5.7%) |
| Mar 2021 | - | -$167.50M(-31.4%) | -$539.50M(-13.7%) |
| Dec 2020 | -$474.48M(-78.2%) | -$127.49M(-6.3%) | -$474.48M(-11.5%) |
| Sep 2020 | - | -$119.94M(+3.7%) | -$425.63M(-18.2%) |
| Jun 2020 | - | -$124.57M(-21.5%) | -$360.22M(-18.1%) |
| Mar 2020 | - | -$102.49M(-30.3%) | -$304.98M(-14.5%) |
| Dec 2019 | -$266.24M(-45.0%) | -$78.64M(-44.2%) | -$266.24M(-5.2%) |
| Sep 2019 | - | -$54.53M(+21.3%) | -$253.19M(-5.4%) |
| Jun 2019 | - | -$69.32M(-8.7%) | -$240.11M(-16.8%) |
| Mar 2019 | - | -$63.75M(+2.8%) | -$205.57M(-11.9%) |
| Dec 2018 | -$183.66M(-318.8%) | -$65.58M(-58.2%) | -$183.66M(-55.5%) |
| Sep 2018 | - | -$41.46M(-19.2%) | -$118.08M(-54.1%) |
| Jun 2018 | - | -$34.78M(+16.9%) | -$76.62M(-83.1%) |
| Mar 2018 | - | -$41.84M | -$41.84M |
| Dec 2017 | -$43.86M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual operating income?
- What is the all-time high annual operating profit for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual operating profit year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly operating profit year-on-year change?
- What is BridgeBio Pharma, Inc. TTM operating income?
- What is the all-time high TTM operating profit for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM operating profit year-on-year change?
What is BridgeBio Pharma, Inc. annual operating income?
The current annual operating profit of BBIO is -$577.37M
What is the all-time high annual operating profit for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual operating income is -$43.86M
What is BridgeBio Pharma, Inc. annual operating profit year-on-year change?
Over the past year, BBIO annual operating income has changed by +$22.08M (+3.68%)
What is BridgeBio Pharma, Inc. quarterly operating income?
The current quarterly operating profit of BBIO is -$133.47M
What is the all-time high quarterly operating profit for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly operating income is $3.74M
What is BridgeBio Pharma, Inc. quarterly operating profit year-on-year change?
Over the past year, BBIO quarterly operating income has changed by +$39.17M (+22.69%)
What is BridgeBio Pharma, Inc. TTM operating income?
The current TTM operating profit of BBIO is -$645.74M
What is the all-time high TTM operating profit for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM operating income is -$41.84M
What is BridgeBio Pharma, Inc. TTM operating profit year-on-year change?
Over the past year, BBIO TTM operating income has changed by -$142.75M (-28.38%)